Format
Sort by

Send to

Choose Destination

Search results

Items: 19

1.

Effects of combined sunitinib and extracranial stereotactic radiotherapy on bone marrow hematopoiesis.

Kao J, Timmins J, Ozao-Choy J, Packer S.

Oncol Lett. 2016 Sep;12(3):2139-2144.

2.

Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial.

Kao J, Chen CT, Tong CC, Packer SH, Schwartz M, Chen SH, Sung MW.

Target Oncol. 2014 Jun;9(2):145-53. doi: 10.1007/s11523-013-0280-y.

3.

Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.

Tong CC, Ko EC, Sung MW, Cesaretti JA, Stock RG, Packer SH, Forsythe K, Genden EM, Schwartz M, Lau KH, Galsky M, Ozao-Choy J, Chen SH, Kao J.

PLoS One. 2012;7(6):e36979. doi: 10.1371/journal.pone.0036979.

4.

Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial.

Kotz T, Federman AD, Kao J, Milman L, Packer S, Lopez-Prieto C, Forsythe K, Genden EM.

Arch Otolaryngol Head Neck Surg. 2012 Apr;138(4):376-82. doi: 10.1001/archoto.2012.187.

PMID:
22508621
5.

Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.

Tong CC, Lau KH, Rivera M, Cannan D, Aguirre-Ghiso J, Sikora AG, Gupta V, Forsythe K, Ko EC, Misiukiewicz K, Gurudutt V, Teng MS, Packer SH, Genden EM, Kao J.

Oncol Rep. 2012 May;27(5):1580-6. doi: 10.3892/or.2012.1679.

PMID:
22322320
6.

Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation.

Ko EC, Genden EM, Misiukiewicz K, Som PM, Kostakoglu L, Chen CT, Packer S, Kao J.

Oncol Rep. 2012 Feb;27(2):467-74. doi: 10.3892/or.2011.1512.

PMID:
22020564
7.

Transoral robotic resection and reconstruction for head and neck cancer.

Genden EM, Kotz T, Tong CC, Smith C, Sikora AG, Teng MS, Packer SH, Lawson WL, Kao J.

Laryngoscope. 2011 Aug;121(8):1668-74. doi: 10.1002/lary.21845.

PMID:
21792953
8.

Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study.

Wisnivesky JP, Smith CB, Packer S, Strauss GM, Lurslurchachai L, Federman A, Halm EA.

BMJ. 2011 Jul 14;343:d4013. doi: 10.1136/bmj.d4013.

9.

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer.

Kao J, Genden EM, Chen CT, Rivera M, Tong CC, Misiukiewicz K, Gupta V, Gurudutt V, Teng M, Packer SH.

Cancer. 2011 Jul 15;117(14):3173-81. doi: 10.1002/cncr.25786.

10.

Disparities in lung cancer stage, treatment and survival among American Indians and Alaskan Natives.

Smith CB, Bonomi M, Packer S, Wisnivesky JP.

Lung Cancer. 2011 May;72(2):160-4. doi: 10.1016/j.lungcan.2010.08.015.

PMID:
20889227
11.

FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma.

Chu MM, Kositwattanarerk A, Lee DJ, Makkar JS, Genden EM, Kao J, Packer SH, Som PM, Kostakoglu L.

Radiographics. 2010 Sep;30(5):1353-72. doi: 10.1148/rg.305095764.

PMID:
20833855
12.

Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.

Kao J, Genden EM, Gupta V, Policarpio EL, Burri RJ, Rivera M, Gurudutt V, Som PM, Teng M, Packer SH.

Cancer. 2011 Jan 15;117(2):318-26. doi: 10.1002/cncr.25374.

13.

The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.

Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, Som PM, Kostakoglu L.

Cancer. 2009 Oct 1;115(19):4586-94. doi: 10.1002/cncr.24493.

14.

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.

Kao J, Packer S, Vu HL, Schwartz ME, Sung MW, Stock RG, Lo YC, Huang D, Chen SH, Cesaretti JA.

Cancer. 2009 Aug 1;115(15):3571-80. doi: 10.1002/cncr.24412. Erratum in: Cancer. 2011 Jun 15;117(12):2826.

15.

Effect of age on survival of clinical stage I non-small-cell lung cancer.

Sigel K, Bonomi M, Packer S, Wisnivesky J.

Ann Surg Oncol. 2009 Jul;16(7):1912-7. doi: 10.1245/s10434-009-0475-8.

PMID:
19408051
16.

Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.

Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP.

Cancer. 2008 Mar 15;112(6):1239-46. doi: 10.1002/cncr.23309.

17.

Prognostic significance of the number of lymph node metastases in esophageal cancer.

Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP.

J Am Coll Surg. 2008 Feb;206(2):239-46. doi: 10.1016/j.jamcollsurg.2007.09.003.

PMID:
18222375
18.
19.

Racial disparities in esophageal cancer treatment and outcomes.

Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, McGinn TG, Wisnivesky JP.

Ann Surg Oncol. 2008 Mar;15(3):881-8.

PMID:
17987341
Items per page

Supplemental Content

Loading ...
Support Center